S. Mathieu

NM 283, AN EFFICIENT PRODRUG OF THE POTENT ANTI-HCV AGENT 2′-C-METHYLCYTIDINE

R. Storer, C. Pierra, S. Benzaria, 2005, Nucleosides, nucleotides & nucleic acids.

Synthesis of a Nucleoside Phosphoramidate Prodrug Inhibitor of HCV NS5B Polymerase: Phenylboronate as a Transient Protecting Group

E. Baloglu, N. Chaudhuri, B. Mayes, 2014 .

Apratoxin A Shows Novel Pancreas-Targeting Activity through the Binding of Sec 61

Zhihong Chen, W. Gerwick, Y. Kotake, 2016, Molecular Cancer Therapeutics.

Prins Reaction of Homoallenyl Alcohols: Access to Substituted Pyrans in the Halichondrin Series.

Dae-Shik Kim, F. Fang, Hui-Lin Fang, 2017, Organic letters.

Stereoselective synthesis of the Halaven C14-C26 fragment from D-quinic acid: crystallization-induced diastereoselective transformation of an α-methyl nitrile.

F. Fang, F. Bélanger, A. Endo, 2015, Angewandte Chemie.

Synthesis and pharmacokinetics of valopicitabine (NM283), an efficient prodrug of the potent anti-HCV agent 2'-C-methylcytidine.

John Mao, R. Storer, J. Sommadossi, 2006, Journal of medicinal chemistry.

E7766, a Macrocycle‐Bridged Stimulator of Interferon Genes (STING) Agonist with Potent Pan‐Genotypic Activity

M. Hao, N. Sarwar, K. Loiacono, 2021, ChemMedChem.

Abstract 4456: Discovery of E7766: A representative of a novel class of macrocycle-bridged STING agonists (MBSAs) with superior potency and pan-genotypic activity

M. Hao, N. Sarwar, K. Loiacono, 2019, Cancer Chemistry.